Get the Stockscreener App
23.79
0.65%
-0.155
Claritev Corp stock is traded at $23.79, with a volume of 42,224.
It is down -0.65% in the last 24 hours and down -33.08% over the past month.
Claritev Corp is a healthcare technology, data, and insights company focused on improving transparency, affordability, and quality. The company provides tech-enabled solutions and services to interpret clients' needs and customize solutions that combine its payment integrity, network-based, and analytics-based services. The company's focus is on being a value-added provider of data analytics and technology-enabled end-to-end cost management, payment, and revenue integrity solutions to the U.S. healthcare industry.
See More
Previous Close:
$23.94
Open:
$23.76
24h Volume:
42,224
Relative Volume:
0.23
Market Cap:
$403.10M
Revenue:
$978.76M
Net Income/Loss:
$-286.52M
P/E Ratio:
-1.3732
EPS:
-17.3212
Net Cash Flow:
$-31.63M
1W Performance:
-2.24%
1M Performance:
-33.08%
6M Performance:
+25.12%
1Y Performance:
-57.57%
1-Day Range:
$23.05
$24.14
1-Week Range:
$22.43
$25.33
52-Week Range:
$11.50
$73.68
Claritev Corp Stock (CTEV) Company Profile
Name
Claritev Corp
Sector
Industry
Phone
212-780-2000
Address
7900 TYSONS ONE PLACE, MCLEAN
Compare CTEV vs VEEV, TEM, BTSG, HNGE, HQY
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CTEV
Claritev Corp
|
23.79 | 403.10M | 978.76M | -286.52M | -31.63M | -17.32 |
VEEV
Veeva Systems Inc
|
312.67 | 50.62B | 3.32B | 941.65M | 1.64B | 5.6161 |
TEM
Tempus Ai Inc
|
69.31 | 12.58B | 1.36B | -302.91M | -219.93M | -1.7182 |
BTSG
Brightspring Health Services Inc
|
62.42 | 12.35B | 13.65B | 169.86M | 412.12M | 1.0758 |
HNGE
Hinge Health Inc
|
105.31 | 8.50B | 646.34M | -512.40M | 202.76M | -6.6871 |
HQY
Healthequity Inc
|
92.42 | 7.64B | 1.34B | 230.70M | 440.96M | 2.6695 |
Claritev Corp Stock (CTEV) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-29-26 | Initiated | Canaccord Genuity | Buy |
| Apr-24-26 | Initiated | Barclays | Overweight |
| Jan-12-26 | Initiated | Guggenheim | Buy |
| Jan-09-26 | Initiated | Wells Fargo | Equal Weight |
| Oct-21-25 | Upgrade | Citigroup | Neutral → Buy |
| May-29-25 | Upgrade | Piper Sandler | Neutral → Overweight |
| Jun-26-24 | Initiated | Piper Sandler | Neutral |
| Dec-13-22 | Downgrade | Citigroup | Buy → Neutral |
| Jul-12-22 | Initiated | Goldman | Neutral |
| Oct-04-21 | Resumed | Citigroup | Buy |
| Apr-07-21 | Initiated | B. Riley Securities | Buy |
| Mar-19-21 | Initiated | Barclays | Equal Weight |
View All
Claritev Corp Stock (CTEV) Latest News
Claritev Corporation (CTEV) stock price, news, quote and history - Yahoo Finance UK
Should You Buy, Hold or Sell Tempus AI Stock Amid AI Boom? - Zacks Investment Research
Claritev: Revenue Growth Is Back, Cash Flow Is The Next Test (NYSE:CTEV) - Seeking Alpha
A Look at Claritev Corp (CTEV) After 11.3% Gain -- GF Value $28. - GuruFocus
Three entities report no Claritev (CTEV) shares, including a private equity investment arm. - stocktitan.net
Claritev Corp (CTEV) Shares Fall 3.7% -- What GF Score of 61 Tel - gurufocus.com
Form 144 CLARITEV CORPORATION For: 27 September By Investing.com - Investing.com Canada
Calif. Appeals Court Revives Antitrust Suit Against Claritev - Law360
Claritev Corporation (CTEV) Stock Price, News, Quote & History - Yahoo! Finance Canada
Douglas Michael Garis Sells 9,025 Shares of Claritev (NYSE:CTEV) Stock - MarketBeat
Claritev : Five Shifts Reshaping TPA Cost Management - marketscreener.com
Claritev (CTEV) CFO sells stock under pre-set plan - Stock Titan
CTEV Looks 10.5% Overvalued on GF Value™ - GuruFocus
Claritev Corporation Is Selected By General Dynamics Information Technology To Support CDC?s World Trade Center Health Program - marketscreener.com
Claritev Selected by GDIT to Support CDC’s World Trade Center Health Program - Business Wire
Planned Claritev (NYSE: CTEV) stock sale tops $278K - Stock Titan
Claritev Corporation Class A Common Stock (NYSE:CTEV) Stock Quote - The Chronicle-Journal
Claritev Corporation (CTEV) Stock Analysis: Unpacking a 44.45% Upside Potential in Healthcare Innovation - DirectorsTalk Interviews
Claritev Corp (CTEV) Stock Down 5.5% but Still Overvalued -- GF Score: 63/100 - GuruFocus
Claritev Releases 2025 Corporate Responsibility Report - Business Wire
Claritev Releases 2025 Corporate Responsibility Report - Yahoo Finance
New Claritev (CTEV) director gets 2,880-share RSU award - Stock Titan
Claritev Appoints Meta AI Research Scientist Ben Letham to Board - citybiz
Claritev Appoints Ben Letham to its Board of Directors - finance.yahoo.com
A Meta AI researcher joins Claritev’s board - Stock Titan
Claritev (NYSE:CTEV) Trading Up 4%Time to Buy? - MarketBeat
Claritev Cares Helps Rural Patients Get Critical Care Closer to Home - Stock Titan
Claritev Cares Helps Rural Patients Get Critical Care Closer to Home - finance.yahoo.com
Claritev’s (CTEV) Profit Picture Brightens, But Its Cash Cushion Shrinks - finance.yahoo.com
Bank of America Corp DE Purchases 58,133 Shares of Claritev $CTEV - MarketBeat
Claritev (NYSE:CTEV) CEO Buys 4,500 Shares of Stock - MarketBeat
Claritev CEO Travis Dalton buys $249,663 in company stock By Investing.com - Investing.com South Africa
Claritev CEO Travis Dalton buys $249,663 in company stock By Investing.com - Investing.com India
Claritev CEO Travis Dalton buys $249,663 in company stock - Investing.com
Claritev CEO Travis Dalton buys $249,663 in company stock By Investing.com - Investing.com Canada
Travis Dalton Purchases 1,950 Shares of Claritev (NYSE:CTEV) Stock - MarketBeat
Claritev (CTEV) CEO adds 6,450 shares via spouse IRA - Stock Titan
Claritev (NYSE:CTEV) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
Is Claritev Corp (CTEV) Overvalued After 9.4% Rally? GF Value Sa - GuruFocus
CTEV Maintained by Barclays -- Price Target Raised to $40.00 - GuruFocus
Claritev (NYSE:CTEV) SVP Tiffani Misencik Sells 8,850 Shares - MarketBeat
Claritev Corp (CTEV) exec sells 8,850 shares, holds 123,723 - Stock Titan
Claritev (NYSE:CTEV) Shares Gap DownHere's Why - MarketBeat
Claritev Chief Growth Officer Tiffani Misencik sells 8,850 shares worth $354,592.95 - Bitget
Claritev says Marpai expands contract for pre- and post-payment claims integrity services - Bitget
CTEV Looks 33.2% Overvalued on GF Value™ - GuruFocus
Marpai expands Claritev agreement for payment integrity By Investing.com - Investing.com Australia
Marpai expands Claritev agreement for payment integrity By Investing.com - Investing.com South Africa
Marpai expands Claritev agreement for payment integrity - Investing.com
Marpai expands beyond network access—but what comes next? - Stock Titan
Claritev Corp Stock (CTEV) Financials Data
Revenue
Net Income
Cash Flow
EPS
Claritev Corp Stock (CTEV) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Douglas Garis | Officer |
Sep 21 '26 |
Proposed Sale |
30.81 |
9,025 |
278,060 |
0 |
| Dalton Travis | Pres., CEO & Executive Chair |
Aug 28 '26 |
Buy |
38.48 |
1,950 |
75,040 |
52,322 |
| Dalton Travis | Pres., CEO & Executive Chair |
Aug 27 '26 |
Buy |
38.81 |
4,500 |
174,623 |
50,372 |
| TIFFANI MISENCIK | Officer |
Aug 14 '26 |
Proposed Sale |
40.07 |
8,850 |
354,592 |
0 |
| Misencik Tiffani | SVP, Chief Growth Officer |
Aug 14 '26 |
Sale |
40.07 |
8,850 |
354,593 |
123,723 |
| WILLIAM MINTZ | Officer |
Aug 10 '26 |
Proposed Sale |
34.24 |
8,431 |
288,677 |
0 |
| Mintz William B. | SVP, Chief Strategy Officer |
Aug 10 '26 |
Sale |
34.24 |
8,431 |
288,677 |
71,195 |
| Carol Nutter | SVP, Chief People Officer |
Jun 09 '26 |
Buy |
28.41 |
875 |
24,856 |
46,941 |
| Prince John Michael | Director |
May 19 '26 |
Buy |
16.00 |
10,000 |
160,000 |
31,662 |
| Kim Michael | EVP, Chief Digital Officer |
May 18 '26 |
Buy |
16.65 |
3,000 |
49,950 |
185,878 |
3.39%
3.47%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):